Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm.
Harry J G M CrijnsArif ElvanNadea Al-WindyYpe S TuiningaErik A BadingsIsmail AksoyIsabelle C Van GelderPrashanti MadhavapeddiAlan John CammPeter R KoweyJeremy N RuskinLuiz Belardinellinull nullPublished in: Circulation. Arrhythmia and electrophysiology (2022)
gov; Unique identifier: NCT03539302.
Keyphrases
- atrial fibrillation
- open label
- liver failure
- oral anticoagulants
- catheter ablation
- left atrial
- respiratory failure
- left atrial appendage
- clinical trial
- direct oral anticoagulants
- phase ii
- aortic dissection
- heart failure
- phase ii study
- phase iii
- drug induced
- study protocol
- percutaneous coronary intervention
- heart rate
- intensive care unit
- mechanical ventilation
- coronary artery disease